NEWS and OPINIONS

US biotech fundraising boom ends 2-year deal drought

US biotech fundraising boom ends 2-year deal drought

By Nicholas Megaw - Fianacial Times - Biotech companies are rushing to raise money in US equity markets at the fastest rate since the peak of the mid-pandemic market boom. Drug developers raised $6.2bn in equity capital markets in January, according to data from...

read more
FDA approves first cell therapy for solid tumors

FDA approves first cell therapy for solid tumors

by Megan Giboney - RegMedNet - The US FDA has granted accelerated approval for AMTAGVI™ (lifileucel), a novel cell therapy for advanced melanoma. This is the first cell therapy to be approved by the FDA for the treatment of a solid tumor. AMTAGVI utilizes a population...

read more
Boosting health equity with lab-grown tissues

Boosting health equity with lab-grown tissues

By University of California Irvine - Popular Science recently chose Quinton Smith, UC Irvine assistant professor of chemical and biomolecular engineering, as one of its Brilliant 10 scientists “on the cusp of changing the world” for his research on growing tissue from...

read more
New CRISPR tool accelerates and optimizes genome editing

New CRISPR tool accelerates and optimizes genome editing

By April Wendling, University of Illinois at Urbana-Champaign - Phys.org - CRISPR/Cas systems have undergone tremendous advancement in the past decade. These precise genome editing tools have applications ranging from transgenic crop development to gene therapy and...

read more
Auto Draft

5 surprising reasons why you should donate blood

By U. Rochester-URMC -  Futuirity - The American Red Cross is experiencing the most critical blood shortage in 20 years. Blood shortages are all too common, but they’re occurring more frequently now than ever before. Contact the Red Cross to find local blood drives...

read more